Screener
Talphera, Inc. TLPH Q2 2026 earnings
Reported August 13, 2026 · After market close
Revenue-
EPS-$0.06Beat by $0.00
EPS estimate-$0.06
“Reaching 75% enrollment in the NEPHRO CRRT study keeps us on track for completion by year-end. Site realignment is complete, with all target clinical sites now activated. We are particularly pleased with the high level of engagement from our principal investigators and study site personnel.”
Next report
Date not yet announcedFinancials
Q2 2026Valuation & ratios
Segments
By segment
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Talphera, Inc. report Q2 2026 earnings?
- Talphera, Inc. (TLPH) reported Q2 2026 earnings on August 13, 2026 after market close.
- What were Talphera, Inc.'s Q2 2026 revenue and EPS?
- Talphera, Inc. reported revenue of - and eps of $-0.06 for Q2 2026.
- Did Talphera, Inc. beat estimates in Q2 2026?
- EPS beat the consensus estimate of $-0.06 by $0.00.
- How did Talphera, Inc.'s Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 40.0% from $-0.10.
- Where can I find Talphera, Inc.'s Q2 2026 SEC filings?
- You can read the 8-K earnings release (0001437749-26-027311) and the 10-Q periodic report (0001437749-26-027316) directly on SEC EDGAR. The filing index links above go to sec.gov.
